MSD Santé Animale France in the news

MSD Santé Animale offers a French-made ear biopsy loop enabling stress-free DNA sampling at birth in one step, improving animal welfare and identification processes.

MSD introduced the first intranasal vaccine for bovine respiratory coronavirus, providing early immunity from birth alongside vaccines for other key respiratory viruses.

MSD introduced the first intranasal vaccine for bovine respiratory coronavirus, providing early immunity from birth alongside vaccines for other key respiratory viruses.

MSD Santé Animale's SenseHub collar monitors calf health from birth to weaning using behavioral algorithms and alerts for early disease detection and optimal weaning.

SenseHub's new monitoring solution tracks young calves' health and development to reduce mortality and optimize weaning through early alerts and activity analysis.

MSD Santé Animale's factory in Eure produces the anabolic Zilmax for cattle, which is banned in France and the EU.

The poultry medicine/pharmaceuticals market is growing rapidly due to increased poultry farming and demand for vaccines, with Asia-Pacific leading and major players like MSD and Elanco driving innovation.

The French veterinary health market is expanding due to increased pet ownership, especially among young people, with strong growth in antiparasitic products and pharmacy sales.

TriRx Pharmaceutical Services took over the former MSD Santé Animale site in Segré, producing veterinary pharmaceuticals for multiple international markets.

Clarisse Lhoste of MSD France was elected president of AGIPHARM, focusing on innovation, healthcare access, and maintaining France's pharma attractiveness.

MSD's SenseHub Dairy device quickly measures somatic cell counts during milking, using LED alerts to help farmers manage udder health and milk quality efficiently.

MSD Santé Animale has rebuilt and expanded its operations in Albi after a major fire, enhancing its production capabilities.

The Innov'Space awards recognized 48 innovations in livestock farming, including MSD Santé Animale's vaccine protecting calves from cryptosporidiosis.

Climate change is causing year-round parasite risks for pets, necessitating consistent anti-parasitic treatments.

MSD Santé Animale introduces a new vaccine for cryptosporidiosis in calves, enhancing animal health management.

Europe's animal health market is growing rapidly, driven by pharmaceuticals, livestock demand, veterinary services, and key players like Ceva and MSD Animal Health.

Allflex develops innovative tracking solutions for animal welfare and identification globally.

MSD Santé Animale launches Bovilis Cryptium vaccine to protect calves from cryptosporidiosis through maternal immunization.

MSD introduces Bovilis Cryptium vaccine to protect calves from cryptosporidiosis through maternal vaccination.

MSD Santé Animale introduces Bovilis Cryptium, a vaccine to combat cryptosporidiosis in calves, reducing clinical symptoms and antibiotic reliance.